Northwest Biotherapeutics Valuation
| NWBO Stock | USD 0.48 0.03 5.88% |
Northwest Biotherapeutics is overvalued. Northwest Biotherapeutics secures a last-minute Real Value of $0.43 per share. The latest price of the firm is $0.48. Our model forecasts the value of Northwest Biotherapeutics from analyzing the firm fundamentals such as Return On Asset of -1.26, shares outstanding of 1.05 B, and Operating Margin of (54.95) % as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Northwest Biotherapeutics' price fluctuation is out of control at this time. Calculation of the real value of Northwest Biotherapeutics is based on 3 months time horizon. Increasing Northwest Biotherapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Northwest Biotherapeutics is useful when determining the fair value of the Northwest otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Northwest Biotherapeutics. Since Northwest Biotherapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Northwest OTC Stock. However, Northwest Biotherapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.48 | Real 0.43 | Hype 0.49 |
The real value of Northwest OTC Stock, also known as its intrinsic value, is the underlying worth of Northwest Biotherapeutics OTC Stock, which is reflected in its stock price. It is based on Northwest Biotherapeutics' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Northwest Biotherapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Northwest Biotherapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Northwest Biotherapeutics helps investors to forecast how Northwest otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Northwest Biotherapeutics more accurately as focusing exclusively on Northwest Biotherapeutics' fundamentals will not take into account other important factors: Northwest Biotherapeutics Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Northwest Biotherapeutics's current stock value. Our valuation model uses many indicators to compare Northwest Biotherapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Northwest Biotherapeutics competition to find correlations between indicators driving Northwest Biotherapeutics's intrinsic value. More Info.Northwest Biotherapeutics is considered to be number one stock in price to earning category among related companies. It is considered to be number one stock in price to sales category among related companies fabricating about 14.77 of Price To Sales per Price To Earning. Comparative valuation analysis is a catch-all model that can be used if you cannot value Northwest Biotherapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Northwest Biotherapeutics' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Northwest Biotherapeutics' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Northwest Biotherapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Northwest Biotherapeutics and how it compares across the competition.
About Northwest Biotherapeutics Valuation
The otc valuation mechanism determines the current worth of Northwest Biotherapeutics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Northwest Biotherapeutics. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of Northwest Biotherapeutics based exclusively on its fundamental and basic technical indicators. By analyzing Northwest Biotherapeutics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Northwest Biotherapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Northwest Biotherapeutics. We calculate exposure to Northwest Biotherapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Northwest Biotherapeutics's related companies.Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company was founded in 1996 and is headquartered in Bethesda, Maryland. Northwest Bioth operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 19 people.
8 Steps to conduct Northwest Biotherapeutics' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Northwest Biotherapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Northwest Biotherapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Northwest Biotherapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Northwest Biotherapeutics' revenue streams: Identify Northwest Biotherapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Northwest Biotherapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Northwest Biotherapeutics' growth potential: Evaluate Northwest Biotherapeutics' management, business model, and growth potential.
- Determine Northwest Biotherapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Northwest Biotherapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Northwest Biotherapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Northwest Biotherapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 948.4 M | |
| Retained Earnings | -1.2 B | |
| Retained Earnings Total Equity | -1.2 B |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Northwest Biotherapeutics. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Northwest Biotherapeutics information on this page should be used as a complementary analysis to other Northwest Biotherapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Northwest OTC Stock analysis
When running Northwest Biotherapeutics' price analysis, check to measure Northwest Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Northwest Biotherapeutics is operating at the current time. Most of Northwest Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Northwest Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Northwest Biotherapeutics' price. Additionally, you may evaluate how the addition of Northwest Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |